Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- N/A
Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy of Ventavis Used in Real-life Setting.
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)
- Status
- WITHDRAWN
- Phase
- PHASE2
FUTURE 3 Study Extension
- Status
- COMPLETED
- Phase
- PHASE3
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
- Status
- TERMINATED
- Phase
- NA
Endothelial Function in Patients With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA
Treprostinil Combined With Tadalafil for Pulmonary Hypertension
- Status
- TERMINATED
- Phase
- PHASE4
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
- Status
- COMPLETED
- Phase
- PHASE4
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
- Status
- COMPLETED
- Phase
- N/A
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
- Status
- COMPLETED
- Phase
- PHASE2
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
- Status
- COMPLETED
- Phase
- PHASE2
Drug Interaction Between Ritonavir And Sitaxsentan
- Status
- WITHDRAWN
- Phase
- PHASE1
Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
- Status
- WITHDRAWN
- Phase
- PHASE1
A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses
- Status
- TERMINATED
- Phase
- PHASE1
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Auto-immunity and Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- NA